Hospitals and research institutes in Guangzhou, Guangdong province, are expanding the clinical use of cell and gene therapies ...
Cell painting has established itself as a powerful tool for high content imaging, able to generate vast quantities of data in response to chemical perturbations. Over the past decade, cell painting ...
SAB selected to advance new therapeutic trials and strategic partnerships EDINBURGH, Scotland, Oct. 26, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm (TCBP)" or the "Company") (NASDAQ: ...
At the Institute for Value-Based Medicine ® event in New Orleans, Louisiana, on November 4, Clark Alsfeld, MD, a hematology and oncology specialist at Ochsner MD Anderson, spoke about the availability ...
Bruker Corporation today announced the launch of the Beacon Discovery ™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop ...
EUDA Health Holdings Limited (NASDAQ: EUDA) ('EUDA” or the 'Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that its ...
The brains of humans and other mammals contain a vast array of neuronal and non-neuronal cell types. The human capacity to process information into complex emotions, behaviours and decisions relies on ...
Building on Bruker’s proprietary Opto-Electrical Positioning (OEP) technology and scalable OptoSelect™ microfluidic chips, Beacon Discovery complements the floor-standing premium Beacon® platforms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback